Summary
Lam Research Corporation (LRCX) reported strong financial results for the quarter ending March 28, 2021, with revenue significantly increasing year-over-year and quarter-over-quarter, driven by robust demand for wafer fabrication equipment and customer support services. The company demonstrated robust profitability, with net income and diluted earnings per share showing substantial growth compared to the prior year period. This performance was supported by solid gross margins, despite some increased manufacturing and employee-related costs. Lam Research continues to invest heavily in research and development to maintain its leadership in critical semiconductor manufacturing processes. The company's balance sheet remains strong, with significant cash and investments, enabling continued share repurchases and dividend payments, underscoring a commitment to returning value to shareholders while navigating a dynamic semiconductor market.
Financial Highlights
54 data points| Revenue | $3.85B |
| Cost of Revenue | $2.07B |
| Gross Profit | $1.78B |
| R&D Expenses | $381.12M |
| SG&A Expenses | $203.70M |
| Operating Expenses | $584.82M |
| Operating Income | $1.20B |
| Interest Expense | $52.24M |
| Net Income | $1.07B |
| EPS (Basic) | $0.75 |
| EPS (Diluted) | $0.74 |
| Shares Outstanding (Basic) | 1.43B |
| Shares Outstanding (Diluted) | 1.45B |
Key Highlights
- 1Revenue for the three months ended March 28, 2021, was $3.85 billion, a significant increase from $2.50 billion in the same period last year, indicating strong market demand.
- 2Net income for the quarter was $1.07 billion, or $7.41 per diluted share, a substantial increase from $574.8 million, or $3.88 per diluted share, in the prior year's quarter.
- 3Gross margin remained strong at 46.3% for the March 2021 quarter, though slightly down from 46.6% in the prior year's quarter, reflecting increased manufacturing costs.
- 4Operating income more than doubled year-over-year, reaching $1.195 billion for the three months ended March 28, 2021, compared to $694.1 million for the same period in 2020.
- 5The company repurchased approximately $1.1 billion of its common stock during the nine months ended March 28, 2021, demonstrating a commitment to returning capital to shareholders.
- 6Investments in Research and Development (R&D) increased to $381.1 million for the three months ended March 28, 2021, up from $307.9 million in the prior year's quarter, highlighting continued focus on innovation.
- 7Cash and cash equivalents, investments, and restricted cash decreased to $6.0 billion at March 28, 2021, from $7.0 billion at June 28, 2020, largely due to share repurchases and dividend payments.